高级检索
当前位置: 首页 > 详情页

X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Key Lab of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China [2]Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China [3]Department of Nephrology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, People’s Republic of China
出处:
ISSN:

关键词: Hepatocellular carcinoma Survival HBx Mutations

摘要:
Hepatitis B virus (HBV) DNA is prone to mutations because of the proofreading deficiencies of HBV polymerase. The postoperative prognostic value of HBV mutations in HBV X protein (HBx) gene was assessed in HBV associated hepatocellular carcinoma (HCC) patients. The HBx gene was amplified and sequenced, the HBV mutations was identified according to NCBI database (http://www.ncbi.nlm.nih.gov/genome/5536). The relationship between the HBV mutations and HCC survival was compared. Survival curves were generated using the Kaplan-Meier method, and comparisons between the curves were made using the log-rank test. Multivariate survival analysis was performed using a Cox proportional hazards model. After adjusting for clinical characteristics, the following eight mutational sites were identified as statistically significant independent predictors of HCC survival: 1383, 1461, 1485, 1544, 1613, 1653, 1719, and 1753. In addition, the following four mutational sites were identified for their association with survival at a border-line significance level: 1527, 1637, 1674, and 1762/1764. A total of 12 mutations in HBx gene region were identified as independent predictors of postoperative survival in HCC patients. The analysis of HBV DNA mutations may help identify patient subgroups with poor prognosis and may help refine therapeutic decisions regarding HCC patients.

基金:

基金编号: 12965519D 13967607D 11275528

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2014]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
JCR分区:
出版当年[2014]版:
Q2 ONCOLOGY
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Hebei Key Lab of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号